Caribou Biosciences (CRBU) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 0.73.
- Caribou Biosciences' Equity Ratio fell 1092.11% to 0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73, marking a year-over-year decrease of 1092.11%. This contributed to the annual value of 0.81 for FY2024, which is 528.23% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Equity Ratio is 0.73, which was down 1092.11% from 0.75 recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Equity Ratio ranged from a high of 0.88 in Q4 2021 and a low of 0.3 during Q2 2021
- Moreover, its 5-year median value for Equity Ratio was 0.81 (2024), whereas its average is 0.76.
- Per our database at Business Quant, Caribou Biosciences' Equity Ratio skyrocketed by 37421.47% in 2022 and then crashed by 1092.11% in 2025.
- Quarter analysis of 5 years shows Caribou Biosciences' Equity Ratio stood at 0.88 in 2021, then fell by 8.18% to 0.8 in 2022, then rose by 5.89% to 0.85 in 2023, then dropped by 5.28% to 0.81 in 2024, then fell by 9.89% to 0.73 in 2025.
- Its Equity Ratio was 0.73 in Q3 2025, compared to 0.75 in Q2 2025 and 0.79 in Q1 2025.